Vimarsana
Biggest News Aggregation in the World

Page 3 - Nasdaq Grcl News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq Grcl. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Grcl Today - Breaking & Trending Today

Gracell Biotechnologies (NASDAQ:GRCL) Sees Unusually-High Trading Volume - Vimarsana News

Gracell Biotechnologies (NASDAQ:GRCL) Sees Unusually-High Trading Volume

Gracell Biotechnologies Inc. (NASDAQ:GRCL – Get Free Report) saw unusually-high trading volume on Wednesday . Approximately 1,041,405 shares changed hands during trading, an increase of 144% from the previous session’s volume of 426,147 shares.The stock last traded at $9.90 and had previously closed at $9.92. Wall Street Analysts Forecast Growth Several research analysts recently commented […]

Gracell Biotechnologies Inc. (NASDAQ:GRCL) Shares Sold by Sphera Funds Management LTD. - Vimarsana News

Gracell Biotechnologies Inc. (NASDAQ:GRCL) Shares Sold by Sphera Funds Management LTD.

Sphera Funds Management LTD. lessened its stake in shares of Gracell Biotechnologies Inc. (NASDAQ:GRCL – Free Report) by 48.0% during the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 1,228,665 shares of the company’s stock after selling 1,131,915 shares during the quarter. Sphera Funds Management […]

Source: wkrb13.com
Gracell Biotechnologies' CEO Dr. William Cao Named to - Vimarsana News

Gracell Biotechnologies' CEO Dr. William Cao Named to

SAN DIEGO and SUZHOU, China and SHANGHAI, China, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Gracell Biotechnologies Inc. (

Gracell Biotechnologies (NASDAQ:GRCL) PT Lowered to $11.00 at Citigroup - Vimarsana News

Gracell Biotechnologies (NASDAQ:GRCL) PT Lowered to $11.00 at Citigroup

Gracell Biotechnologies (NASDAQ:GRCL – Free Report) had its target price decreased by Citigroup from $12.00 to $11.00 in a research note issued to investors on Tuesday morning, Benzinga reports. Citigroup currently has a buy rating on the stock. Other equities analysts have also issued reports about the stock. BTIG Research raised their target price on […]

Gracell Biotechnologies Inc. (NASDAQ:GRCL) Short Interest Update - Vimarsana News

Gracell Biotechnologies Inc. (NASDAQ:GRCL) Short Interest Update

Gracell Biotechnologies Inc. (NASDAQ:GRCL – Get Free Report) was the recipient of a significant increase in short interest in August. As of August 15th, there was short interest totalling 799,100 shares, an increase of 6.8% from the July 31st total of 748,300 shares. Currently, 1.0% of the company’s stock are short sold. Based on an […]